A new pilot study from The Conference Board and the Impact Genome Project® (IGP) introduces standardized social outcomes to help measure and compare the performance of societal investments. The standardized outcomes allow for benchmark metrics, including efficacy rates and cost per outcome. The study used data from 16 companies whose funding contributed to nearly 650 nonprofit programs. The benchmarks provide new insights into the effectiveness of corporate societal investments.
This publication is complimentary.
To gain access to it and our other free content, click "Read more" and create an account.